Chris S.
About Chris S.
Chris S. is the Innovator Support Team Lead and Senior Regulatory Specialist at the National Institutes of Health, where he coordinates a team to advance innovative technologies in human health. He holds a BA in Chemistry from Whittier College and a PhD in Pharmaceutical Sciences from the University of Maryland Baltimore.
Work at National Institutes of Health
Chris S. currently serves as the Innovator Support Team Lead and Senior Regulatory Specialist at the National Institutes of Health (NIH). In this role, he coordinates a team that specializes in product development, business strategy, and regulatory affairs. His work involves close collaboration with NIH program staff and researchers focused on advancing innovative technologies that impact human health. Since joining NIH in 2019, he has been instrumental in enabling the innovator community to navigate the complexities of scientific and biological limitations to progress their discoveries.
Education and Expertise
Chris S. holds a Bachelor of Arts in Chemistry from Whittier College, where he studied from 1996 to 2002. He also earned a PhD in Pharmaceutical Sciences from the University of Maryland Baltimore, completing his studies from 1986 to 1990. His educational background provides a strong foundation for his work in regulatory affairs and product development within the healthcare sector.
Background
Before his current position at NIH, Chris S. held various roles that contributed to his expertise in regulatory affairs. He worked as a Regulatory Specialist at the National Heart, Lung, and Blood Institute from 2012 to 2019. Prior to that, he served as a Project Director at Social & Scientific Systems from 2007 to 2012. His experience also includes a role as a Regulatory Affairs Officer at the National Institute of Allergy and Infectious Diseases for seven months in 2012 and as a Cancer Research Training Award Postdoctoral Fellow at the National Cancer Institute from 2003 to 2005.
Professional Experience
Chris S. has extensive experience in regulatory affairs and project management within the healthcare industry. He worked at the FDA as an Interagency Oncology Task Force Fellow from 2005 to 2007. His diverse roles have equipped him with a comprehensive understanding of the regulatory landscape, which he applies in his current position to support innovators in advancing their health-related discoveries.